Search the global news on our network companies
A comprehensive source of news from our network. With the latest from companies appearing on our platform, around the globe, we deliver an extensive summary of news, press releases and information directly from the companies and other authoritative industry news sources.
Search and filter the results by company or location to find the news that matters to you.
If you would like to publish news on behalf of your company, please register with us at the following link https://www.pharmaservicesdirectory.com/register
Save
This Search |
View as Grid
| Order by Recently Added
| Order
by Company Name
- Total Results: 951
- Total Pages: 119
Oncodesign Precision Medicine and Navigo Proteins GmbH sign a strategic collaboration agreement
Dijon (France), May 15, 2024, at 6:00pm CEST– Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Mnemonic: ALOPM), a biopharmaceutical company specializing in precision medicine for the treatment of resistant and metastatic cancers, and Navigo Proteins GmbH (Halle, Germany), a biopharmaceutical company specializing in the discovery and development of Precision Medicine applications based on the Affilin® technology platform, announce the signature of a strategic collaboration agreement for the discovery and development of new systemic radiotheranostic…
Read more on this story »
Manage Your Profile
COVERIS INVESTS MILLIONS IN PRODUCTION CAPACITY
In response to the growing demand for high-quality packaging solutions for the medical sector, the Coveris Group is investing considerably in production capacity for medical device packaging at its Rohrdorf and Halle sites in Germany.
Leading packaging manufacturer Coveris is investing more than eight million euros in the coming months to upgrade and expand its medical device production lines.
View original story »
Manage Your Profile
TriLink BioTechnologies collaborates with Johns Hopkins University to establish a new RNA Innovation Center
San Diego, U.S. (May 13, 2024) – TriLink BioTechnologies (TriLink®), a Maravai™ LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, is collaborating with the Johns Hopkins University to accelerate transformational research in RNA therapeutics and discovery. A new center within the Johns Hopkins Whiting School of Engineering will accelerate research and the...
View original story »
Manage Your Profile
Circio presents pre-clinical proof-of-concept data for its circVec gene therapy platform at the ASGCT 2024 meeting
Oslo, Norway, 13 May 2024 – Circio Holding ASA (OSE: CRNA), a biotechnology company developing circular RNA-based gene therapy, today announces that it has presented two posters that demonstrate in vivo proof-of-concept for its powerful and differentiated circVec platform approach to gene therapy. The two posters were presented at the American Society of Gene & Cell Therapy (ASGCT) 2024 annual meeting 7-11 May in Baltimore, USA
View original story »
Manage Your Profile
Ribobay Pharma Integrates Cytvia’s FlexFactory Platform for Oligonucleotides
Will rapidly expand its oligo CRDMO business, producing several hundred kilograms of pharmaceutical oligo per year.
View original story »
Manage Your Profile
Rakovina Therapeutics Announces Strategic Pivot to being a AI Company
Leveraging Deep Docking AI Drug Discovery Platform
View original story »
Manage Your Profile
ExcellGene SA and Cytovance Biologics Join Forces to Transform Large Molecule Biologics Development and Manufacture
OKLAHOMA CITY, Oklahoma, MONTHEY, Switzerland, May 8, 2024 – ExcellGene SA, a leading Swiss biotech service provider specializing in mammalian cell line development for more than two decades, proudly announces its strategic collaboration with Cytovance Biologics, a renowned Contract Development and Manufacturing Organization (CDMO) based in the USA.
View original story »
Manage Your Profile
Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration
Collaboration combines Repertoire’s industry leading DECODE™ platform that uniquely maps the immune synapse to develop T cell targeted immune medicines with Bristol Myers Squibb’s world-leading expertise in developing and commercializing innovative immune medicines
Repertoire will receive an upfront payment of $65 million and is eligible to receive up to $1.8 billion in milestone and other payments and tiered royalties
View original story »
Manage Your Profile
- Total Results: 951
- Total Pages: 119
Network News
Keeping the latest and up-to-date news on our companies is a key activity of the editorial team.
We support companies directly through the profiles to allow them update their profile with the latest news and company announcements. Search fields are provided so that you can access news by company name, sector e.g research, manufacturing, equipment, packaging or geography.
The global news is updated daily and its aim is to provide you as a directory user with the information needed to make good buying or supply choices. News covers companies operating within the pharmaceutical, biotechnology, medical device and nutraceutical sectors.
Also through our software applications you can evaluate, rate and score news and company announcements to support corporate risk management activities. Through the software applications it is possible to supplement and add your own news items, keeping a library of news activities on any company identified through the directory.
Take the Next Step
Should you have any questions or require further information please contact us ...
Contact the support team »
Check if your company is listed and claim your online profile ...
Search for your company listing »
If you're not listed in the directory and you want to build a public profile, register for an account ...
Register for an account to build a profile »
Apply for a free trial of our Supplier Management Software ...
Register for an account to trial the software »
